EMJ Nephrology 9.4 2021

CHRONIC kidney disease (CKD) affects approximately 700 million individuals worldwide. Many patients with CKD require haemodialysis, and more than two-thirds of these patients have CKD-associated pruritus (CKD-aP). CKD-aP can be bothersome for many patients and drastically affect quality of life, from causing sleep issues to mental health problems. Almost 40% of dialysis patients are at least ‘moderately’ bothered and 19% of patients are at least very much bothered by pruritus.